Literature DB >> 6345094

Cholinesterase and succinylcholine.

J Viby-Mogensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6345094

Source DB:  PubMed          Journal:  Dan Med Bull        ISSN： 0907-8916


× No keyword cloud information.
  6 in total

Review 1.  [The development of pharmacogenetics--a retrospective on the 75th birthday of Hans Herken].

Authors:  W Kalow
Journal:  Klin Wochenschr       Date:  1988-03-15

2.  Factors affecting inter-individual variation in human plasma cholinesterase activity: body weight, height, sex, genetic polymorphism and age.

Authors:  A Brock; V Brock
Journal:  Arch Environ Contam Toxicol       Date:  1993-01       Impact factor: 2.804

3.  Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing.

Authors:  B N La Du; C F Bartels; C P Nogueira; M Arpagaus; O Lockridge
Journal:  Cell Mol Neurobiol       Date:  1991-02       Impact factor: 5.046

Review 4.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

5.  Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase.

Authors:  U Bang; L Nyberg; J Rosenborg; J Viby-Mogensen
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

Review 6.  Adverse reactions and interactions of the neuromuscular blocking drugs.

Authors:  D Ostergaard; J Engbaek; J Viby-Mogensen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.